id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0446-0025,FDA,FDA-2013-D-0446,Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers; Guidance for Industry,Other,Guidance,2025-11-17T05:00:00Z,2025,11,2025-11-17T05:00:00Z,,2025-11-17T19:59:51Z,,1,0,09000064b90857a2
FDA-2013-D-0446-0024,FDA,FDA-2013-D-0446,Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers; Guidance for Industry; Availability,Notice,Notice of Availability,2025-11-17T05:00:00Z,2025,11,2025-11-17T05:00:00Z,,2025-11-17T19:38:16Z,2025-19984,0,0,09000064b9085097